R. Clinton Webb

R. Clinton Webb

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


R. Clinton Webb has a total of 78 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Gut–immune–PVAT axis is involved in ethanol-induced abdominal aortic dysfunction via IL-17RA, TLR4, and FPR1 signaling

    by Carla Brigagão Pacheco da Silva, Vanessa Fernandes Rodrigues, Daniela Carlos, Maria Cecília Jordani, Leandra Naira Zambelli Ramalho, José Teles de Oliveira-Neto, Jefferson Elias-Oliveira, Marília Cristina Oliveira Souza, Rafael Menezes da Costa, Mirele Resende Machado, et al.

    1. According to the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, alcohol use represents the leading risk factor for disability-adjusted life-years (DALYs) in the 25–49-ye...

  • Hypertension Summer School sponsored by American Journal of Hypertension, July 25-29, 2024, Loyola University, Chicago, Illinois

    by Karen A Griffin, Fernanda B M Priviero, Cameron G McCarthy, Katherine T Mills, Carolina B Restini, Rinaldo Rodrigues dos Passos, Raymond R Townsend, Mark J Uline, Emma Wabel, Stephanie W Watts, et al.

    The Hypertension Summer School sponsored by the American Journal of Hypertension was held at Loyola University, Chicago, July 25-29, 2024. Its goal was to provide interdisciplinary education, practical training, mentorship, and professional development for emerging investigators and clinicians in hypertension. More than 100 trainees from the United States and nine additional countries participated with 32 internationally recognized faculty members. The curriculum addressed hypertension epidemiology and health equity; neural, immune, renal, vascular, cardiac, and hormonal mechanisms; pregnancy-associated and transgender hypertension; blood pressure measurement; resistant hypertension; pharmacotherapy; animal models; computational approaches; artificial intelligence; bioengineering; remote monitoring; and emerging lifestyle and therapeutic strategies. Hands-on sessions in blood pressure assessment, including pulse wave velocity and central pressure waveform measurement, complemented didactic instruction. Career-development programming and structured networking activities promoted mentorship, interdisciplinary interaction, and professional identity formation. Participant feedback indicated that the program successfully integrated contemporary science, clinical relevance, technical training, and collegial engagement. The Summer School illustrates the value of immersive, international educational programs in developing the next generation of hypertension researchers and health professionals. The next American Journal of Hypertension-sponsored Summer School will be held at Loyola University Chicago, July 22-26, 2027.

  • Open Access

    Mechanistic Insights on Immune Activation-Driven Erectile Dysfunction: Evidence from Animal Models

    by Tiago T. Gonçalves, Raiana dos Anjos Moraes, Rinaldo Rodrigues dos Passos, Clinton Webb, Fernanda Priviero

    Purpose of Review: Erectile dysfunction (ED) has traditionally been attributed to impaired hemodynamics and reduced nitric oxide (NO) bioavailability. This review examines current evidence supporting immune activation and inflammation as shared mechanisms contributing to ED across diverse pathological conditions. Recent Findings: Experimental studies demonstrate that diabetes, hypertension, obesity, aging, nerve injury, and psychological stress are associated with activation of inflammatory pathways including NF-κB, Toll-like receptors, and the NLRP3 inflammasome. These pathways interact with oxidative stress and endothelial dysfunction to promote cytokine production, fibrosis, smooth muscle loss, and inflammatory cell death. Summary: Current evidence identifies inflammatory and innate immune pathways as convergent pathogenic drivers of ED across diverse etiologies. Rather than representing passive consequences of underlying disease, these mechanisms actively contribute to vascular, neural, and structural dysfunction, perpetuating processes that promote erectile impairment. Recognizing the central role of immune-mediated dysfunction in ED may facilitate the development of novel therapeutic strategies targeting disease mechanisms rather than symptoms alone.

  • Endothelial Dysfunction in Vascular Inflammation: The Role of NLRP3, NLRP10, AIM2, TLR9, and PANoptosis

    by Diana L. Silva-Velasco, Rinaldo R. Dos Passos, Raiana Anjos Moraes, Tiago Tomazini Gonçalves, Stephanie Wilczynski, Tianxin Zhang, Stephanie Randar, Jeremiah Tobin, Mark J. Uline, Fernanda Priviero, et al.

    Endothelial dysfunction is a hallmark of vascular inflammation and a critical step in the development of cardiovascular diseases. Recent evidence highlights the role of inflammasome factors in the inflammatory and cell death pathways that compromise endothelial homeostasis. NLRP3 and AIM2 inflammasomes drive the release of IL-1β and IL-18, amplifying vascular inflammation, while TLR9 responds to mitochondrial DNA to further potentiate endothelial secretion of inflammatory cytokines. In contrast, NLRP10 appears to act as a modulator of inflammasome activity and NF-κB signaling. Together, these sensors converge on processes such as pyroptosis, apoptosis, and necroptosis, which can integrate into PANoptosis, thereby exacerbating endothelial injury. Understanding these mechanisms offers new insights into the interplay between innate immunity and vascular dysfunction, with potential implications for therapeutic interventions.


  • Open Access

    Adipose Triglyceride Lipase and Gpr40 Contribute to the Anti‐Contractile Effect of Perivascular Adipose Tissue

    by Miranda Hyatt, Rinaldo Rodrigues Dos Passos, Fenix A. Araujo, Emily W. Wilson, Emily W. Waigi, Tiago J. Costa, Darízy F. Silva, R. Clinton Webb, Camilla F. Wenceslau, Cameron G. McCarthy

    Objective: Perivascular adipose tissue (PVAT) surrounds most peripheral blood vessels and exerts an anti‐contractile influence through paracrine mediators. Although numerous vasoactive factors have been identified, the mechanisms linking adipocyte metabolism to PVAT‐dependent modulation of vascular tone remain poorly defined. Because adipocytes store energy as triglycerides hydrolyzed by adipose triglyceride lipase (ATGL) and hormone‐sensitive lipase (HSL) to generate free fatty acids, we hypothesized that lipolysis‐derived fatty acids may contribute to PVAT's anti‐contractile actions through activation of long‐chain fatty acid‐sensing G protein‐coupled receptors, Gpr40 and/or Gpr120. Methods: Mesenteric resistance arteries (MRAs) from adult Wistar rats were studied using wire myography, with or without PVAT, and pharmacological agonists/antagonists and endothelial denudation were used to study signaling. To examine changes in hypertension, PVAT and MRAs from spontaneously hypertensive rats (SHRs) were analyzed by western blotting, and plasma from non‐fasting or fasting SHR was assessed by untargeted lipidomics. Results: In Wistar rats, inhibition of ATGL, but not HSL, abolished PVAT's anti‐contractile effect, and blockade of Gpr40, but not Gpr120, similarly diminished this response, identifying ATGL and Gpr40 as important mediators. Activation of Gpr40 in PVAT‐ and endothelium‐denuded MRAs further recapitulated the anti‐contractile effect in a β‐arrestin‐dependent manner. In SHR, PVAT ATGL expression was significantly upregulated and MRA Gpr40 expression tended to increase. However, circulating Gpr40 ligand abundance was largely unchanged between strains, suggesting that impaired ligand availability is unlikely to underlie PVAT dysfunction in hypertension. Conclusions: These findings identify a previously unrecognized ATGL‐Gpr40 signaling axis linking adipocyte triglyceride metabolism to PVAT‐mediated regulation of vascular tone.

  • Open Access

    Erectile and Clitoral Dysfunction as Harbingers of Cardiovascular Disease: A Perspective

    by Fernanda Priviero, Fiona Hollis, Susan K. Wood, Mark Uline, Karl-Erik Andersson, R. Clinton Webb

    Sexual dysfunction (SD), more specifically vasculogenic erectile dysfunction (ED) in men and female sexual arousal disorder (FSAD) in women, is increasingly recognized as a marker of cardiovascular disease (CVD). While extensive literature documents vasculogenic ED as an early warning sign of coronary artery disease (CAD) and other atherosclerotic manifestations, the evidence for analogous phenomena in women is emerging but less mature. This perspective explores epidemiologic associations, shared pathophysiologic mechanisms, clinical implications, and screening paradigms for ED and FSAD as cardiovascular (CV) risk-enhancing conditions. This perspective endorses that clinicians should incorporate genital vasculogenic SD into CV risk stratification and that multidisciplinary care (primary care, cardiology, urology/gynecology) is warranted. A summary table outlines key features and actionable steps.


  • Sex-specific vascular effects of menthol: TRPM8- and TRPA1-dependent relaxation in female mouse aorta and pudendal arteries

    by Fênix Alexandra Araujo, Raiana Anjos Moraes, Rinaldo Rodrigues dos Passos, Milene Tavares Fontes, Camilla Ferreira Wenceslau, R. Clinton Webb, Fernanda Priviero, Cameron G. McCarthy, Darízy Flávia Silva

    Sexual dysfunction affects the quality of life for both men and women. Menthol, a TRPM8 agonist, is widely used in products to enhance sexual performance due to its cooling effect. Beyond this, menthol also induces vascular effects in male arteries. To explore its effects on female vasculature, we studied male and female C57BL/6 mice, along with female TRPM8 knockout (KO) mice. We isolated the internal pudendal artery and aorta to assess isometric contractile force. Menthol-induced relaxation of the pudendal artery was reduced in both female TRPM8 KO and male mice compared to female controls. Acetylcholine-induced relaxation was not affected in females, but in males, it was attenuated by menthol and enhanced by M8-B, a TRPM8 inhibitor. Menthol did not alter responses to norepinephrine, serotonin, or histamine in either sex. Notably, menthol-induced relaxation was also reduced in the aortas of female TRPM8 KO mice. In both the aorta and pudendal arteries of female mice, the TRPA1 inhibitor HC030031 significantly diminished menthol-induced relaxation. These findings suggest that TRPM8 modulation plays a role in acetylcholine-induced relaxation in male, but not female, pudendal arteries. Moreover, the menthol vascular effect in female arteries relies on TRPM8 and TRPA1 activation.


  • Open Access

    RhoA/Rho-Kinase Signaling in Vascular Smooth Muscle and Endothelium: Mechanistic Insights and Translational Implications in Hypertension

    by Stephanie Randar, Diana L. Silva-Velasco, Fernanda Priviero, R. Clinton Webb

    The small GTPase RhoA and its downstream effector Rho-kinase (ROCK) have emerged as pivotal regulators of vascular smooth muscle cell (VSMC) contraction, endothelial function, and vascular remodeling. Activation of the RhoA/ROCK pathway enhances calcium (Ca2+) sensitivity by inhibiting myosin light chain phosphatase (MLCP), thereby promoting sustained vascular tone independent of intracellular Ca2+ levels. In endothelial cells (ECs), RhoA/ROCK signaling contributes to nitric oxide (NO) dysregulation, oxidative stress, cytoskeletal reorganization, and inflammatory activation. Cumulative evidence implicates this pathway in the development and progression of hypertension and other cardiovascular diseases, where maladaptive vascular remodeling, VSMC proliferation, and endothelial dysfunction drive increased vascular resistance. Translational studies have identified ROCK inhibitors and indirect modulators such as statins as promising therapeutic strategies. This review integrates recent mechanistic insights into RhoA/ROCK regulation of vascular function with clinical and translational perspectives on targeting this pathway in hypertension.


  • Open Access

    Polo-like Kinase 1 Activation Regulates Angiotensin II-Induced Contraction in Pudendal and Small Mesenteric Arteries from Mice

    by Raiana Anjos Moraes, Olufunke O. Arishe, James Pratt, Stephanie Wilczynski, Rinaldo Rodrigues dos Passos, Diana L. Silva-Velasco, Tiago Tomazini Gonçalves, Tianxin Zhang, Darizy Flavia Silva, R. Clinton Webb, et al.

    Polo-like kinase 1 (PLK1) is a serine/threonine protein kinase expressed in smooth muscle cells (SMCs), with emerging roles in regulating contraction. We hypothesize that PLK1 contributes to smooth muscle contractility in pudendal arteries (PA), small mesenteric arteries (SMA), and the corpus cavernosum (CC). Using male C57BL/6J mice, we assessed mRNA and protein expression of PLK1 in these tissues. In addition, the arteries and CC were mounted in myographs for isometric force measurement. We then investigated whether PLK1 regulates SMC contractility induced by phenylephrine (PE), U46619, and angiotensin II (Ang II) in arteries, and by PE, serotonin (5-HT), and electrical field stimulation (EFS; 1–16 Hz) in the CC, both in the presence and absence of the PLK1 inhibitor volasertib. PLK1 expression was confirmed in the SMA, PA, and CC by RT-qPCR or Western blotting. Notably, PLK1 inhibition significantly reduced Ang II-induced contraction in the PA and SMA and attenuated EFS-induced contraction at 2 and 4 Hz in the CC. In contrast, responses to PE, U46619, and 5-HT were unaffected by PLK1 inhibition. These results suggest that PLK1 selectively mediates contraction in response to Ang II and neurogenic stimuli. PLK1 may therefore represent a novel, stimulus-specific regulator of vascular and erectile smooth muscle contractility.